Kawasaki E, Matsuura N, Eguchi K
Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University Hospital of Medicine and Dentistry, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Diabetologia. 2006 May;49(5):828-36. doi: 10.1007/s00125-006-0213-8. Epub 2006 Mar 28.
Type 1 diabetes is a multifactorial disease which results from a T-cell-mediated autoimmune destruction of the pancreatic beta cells in genetically predisposed individuals. The risk for individuals of developing type 1 diabetes varies remarkably according to country of residence and race. Japan has one of the lowest incidence rates of type 1 diabetes in the world, and recognises at least three subtypes of the condition: acute-onset ('classical'), slow-onset, and fulminant type 1 diabetes. The incidence rate of type 1 diabetes in children aged 0-14 years in Japan increased over the period from 1973-1992, but remained constant over the last decade, averaging 2.37 cases per 100,000 persons per year; the incidence does not appear to have increased in older age groups. Although there are few reports regarding the incidence and prevalence of type 1 diabetes in adult-onset patients, it appears that the prevalence of type 1 diabetes in adults is more than twice that in childhood-onset patients and that two-thirds of them have a slow-onset form of type 1 diabetes. Differences and similarities in the association of MHC and non-MHC genes with type 1 diabetes are observed in Japan and in countries with Caucasoid populations. Highly susceptible class II HLA haplotypes identified in patients of Caucasoid origin are rarely seen in Japanese patients, whereas protective haplotypes are universal. Non-MHC genes associated with susceptibility to type 1 diabetes in both Japanese and Caucasoid patients include polymorphisms in the insulin gene, the cytotoxic T-lymphocyte antigen 4 (CTLA4) gene, the interleukin-18 (IL18) gene and the major histocompatibility complex class I chain-related gene A (MICA) gene. Fulminant type 1 diabetes is a unique subtype of type 1 diabetes that accounts for about 20% of acute-onset type 1 diabetes, and is seen mainly in adults. The challenge for the future is to investigate the underlying pathogenesis of beta cell destruction, including the genetic or environmental factors that may modify the form of onset for each subtype of Japanese type 1 diabetes.
1型糖尿病是一种多因素疾病,在具有遗传易感性的个体中,由T细胞介导的胰腺β细胞自身免疫性破坏所致。1型糖尿病的发病风险因居住国家和种族的不同而有显著差异。日本是世界上1型糖尿病发病率最低的国家之一,并且至少识别出该疾病的三种亚型:急性起病型(“经典型”)、缓慢起病型和暴发性1型糖尿病。1973年至1992年期间,日本0至14岁儿童的1型糖尿病发病率有所上升,但在过去十年中保持稳定,平均每年每10万人中有2.37例;老年人群的发病率似乎并未上升。虽然关于成人起病型患者中1型糖尿病的发病率和患病率的报道较少,但成人1型糖尿病的患病率似乎是儿童起病型患者的两倍多,其中三分之二为缓慢起病型1型糖尿病。在日本和白种人人群的国家中,观察到MHC和非MHC基因与1型糖尿病关联的异同。在白种人起源的患者中鉴定出的高度易感的II类HLA单倍型在日本患者中很少见,而保护性单倍型则很普遍。在日本和白种人患者中,与1型糖尿病易感性相关的非MHC基因包括胰岛素基因、细胞毒性T淋巴细胞抗原4(CTLA4)基因、白细胞介素18(IL18)基因和主要组织相容性复合体I类链相关基因A(MICA)基因的多态性。暴发性1型糖尿病是1型糖尿病的一种独特亚型,约占急性起病型1型糖尿病的20%,主要见于成年人。未来的挑战是研究β细胞破坏的潜在发病机制,包括可能改变日本1型糖尿病各亚型发病形式的遗传或环境因素。